Diagnostic company Exact Sciences to buy Genomic Health in US$2.8 billion deal

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 66%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

REUTERS: Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about US$2.8 billion in cash and stock, expanding the cancer ...

REUTERS: Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about US$2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers.

Shares of Genomic Health rose 2.7per cent to US$70.51 in early trading, while Exact Sciences' shares fell 12.1per cent to US$103.6. Colorectal cancer testing represents a US$15 billion opportunity in the U.S., according to Exact Sciences.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines